477 related articles for article (PubMed ID: 34203237)
1. The Comprehensive "Omics" Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy.
Yoon SJ; Lee CB; Chae SU; Jo SJ; Bae SK
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203237
[TBL] [Abstract][Full Text] [Related]
2. T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs).
Rallis KS; Hillyar CRT; Sideris M; Davies JK
Anticancer Res; 2021 Mar; 41(3):1123-1141. PubMed ID: 33788704
[TBL] [Abstract][Full Text] [Related]
3. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.
Bagchi S; Yuan R; Engleman EG
Annu Rev Pathol; 2021 Jan; 16():223-249. PubMed ID: 33197221
[TBL] [Abstract][Full Text] [Related]
5. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Naimi A; Mohammed RN; Raji A; Chupradit S; Yumashev AV; Suksatan W; Shalaby MN; Thangavelu L; Kamrava S; Shomali N; Sohrabi AD; Adili A; Noroozi-Aghideh A; Razeghian E
Cell Commun Signal; 2022 Apr; 20(1):44. PubMed ID: 35392976
[TBL] [Abstract][Full Text] [Related]
6. Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.
Bracci L; Fragale A; Gabriele L; Moschella F
Front Immunol; 2020; 11():582744. PubMed ID: 33193392
[TBL] [Abstract][Full Text] [Related]
7. Application of omics techniques in forensic entomology research.
Shao S; Yang L; Hu G; Li L; Wang Y; Tao L
Acta Trop; 2023 Oct; 246():106985. PubMed ID: 37473953
[TBL] [Abstract][Full Text] [Related]
8. Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies.
Augustin RC; Cai WL; Luke JJ; Bao R
Clin Cancer Res; 2024 May; 30(9):1724-1732. PubMed ID: 38236069
[TBL] [Abstract][Full Text] [Related]
9. Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy.
Dora D; Bokhari SMZ; Aloss K; Takacs P; Desnoix JZ; Szklenárik G; Hurley PD; Lohinai Z
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769093
[TBL] [Abstract][Full Text] [Related]
10. Second Era of OMICS in Caries Research: Moving Past the Phase of Disillusionment.
Nascimento MM; Zaura E; Mira A; Takahashi N; Ten Cate JM
J Dent Res; 2017 Jul; 96(7):733-740. PubMed ID: 28384412
[TBL] [Abstract][Full Text] [Related]
11. Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.
Chakraborty S; Hosen MI; Ahmed M; Shekhar HU
Biomed Res Int; 2018; 2018():9836256. PubMed ID: 30402498
[TBL] [Abstract][Full Text] [Related]
12. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.
Zhang J; Dai Z; Yan C; Zhang W; Wang D; Tang D
Clin Transl Oncol; 2021 Dec; 23(12):2415-2430. PubMed ID: 34125407
[TBL] [Abstract][Full Text] [Related]
13. An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer.
Wang KW; Wang MD; Li ZX; Hu BS; Wu JJ; Yuan ZD; Wu XL; Yuan QF; Yuan FL
Front Immunol; 2022; 13():992060. PubMed ID: 36311733
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome and cancer immunotherapy.
Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review of Multi-Omics Approaches to Investigate Toxicological Effects in Macrophages.
Karkossa I; Raps S; von Bergen M; Schubert K
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317022
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics study for interpretation of genome-wide association study.
Akiyama M
J Hum Genet; 2021 Jan; 66(1):3-10. PubMed ID: 32948838
[TBL] [Abstract][Full Text] [Related]
17. News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors.
Melaiu O; Lucarini V; Giovannoni R; Fruci D; Gemignani F
Semin Cancer Biol; 2022 Feb; 79():18-43. PubMed ID: 32659257
[TBL] [Abstract][Full Text] [Related]
18. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.
Hernández-Vargas P; Muñoz M; Domínguez F
Hum Reprod Update; 2020 Feb; 26(2):264-301. PubMed ID: 32096829
[TBL] [Abstract][Full Text] [Related]
19. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
